Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
08.08.24
/
50%
€115.00
Target price
08.08.25
€146.66
Performance (%)
7.80%
Price
16:21
€123.50
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 7.80%. A total of €0.46 was paid as dividends for this prediction. This prediction currently runs until 08.08.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | 4.661% | 4.661% |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target lowered by analysts at BMO Capital Markets from $170.00 to $160.00. They now have an "outperform" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€137.00
25.06.24
25.06.24
€152.14
25.06.25
25.06.25
-9.15%
16:21
16:21
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€119.50
12.04.24
12.04.24
€153.17
12.04.25
12.04.25
4.15%
16:21
16:21